News

Published on 21 Mar 2024 on Simply Wall St. via Yahoo Finance

Chemed Corporation's (NYSE:CHE) Stock Is Going Strong: Have Financials A Role To Play?


Article preview image

Most readers would already be aware that Chemed's (NYSE:CHE) stock increased significantly by 10% over the past month. We wonder if and what role the company's financials play in that price change as a company's long-term fundamentals usually dictate market outcomes. Specifically, we decided to study Chemed's ROE in this article.

ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. Simply put, it is used to assess the profitability of a company in relation to its equity capital.

View our latest analysis for Chemed

NYSE.CHE price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Chemed (CHE) Lags Q1 Earnings Estimates, Reaffirms 2024 View

Chemed Corporation CHE reported adjusted earnings per share (EPS) of $5.20 in the first quarter o...

Zacks via Yahoo Finance 25 Apr 2024

Here's Why You Should Retain Chemed (CHE) Stock for Now

Chemed Corporation CHE is well-poised for growth in the coming quarters, backed by the strong per...

Zacks via Yahoo Finance 17 Apr 2024

Chemed Corporation (CHE) Rose 13% in Q4

TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus...

Insider Monkey via Yahoo Finance 3 Apr 2024

Chemed Corp Executive Vice President Spencer Lee Sells Company Shares

Chemed Corp (NYSE:CHE), a company that operates through its two wholly-owned subsidiaries, VITAS ...

GuruFocus.com via Yahoo Finance 1 Apr 2024

Chemed Corporation's (NYSE:CHE) Stock Is Going Strong: Have Financials A Role To Play?

Most readers would already be aware that Chemed's (NYSE:CHE) stock increased significantly by 10%...

Simply Wall St. via Yahoo Finance 21 Mar 2024

Chemed (CHE) Reaches a New 52-Week High: What's Driving It?

Shares of Chemed Corporation CHE reached a new 52-week high of $654.62 on Mar 15, 2024, before cl...

Zacks via Yahoo Finance 18 Mar 2024

Chemed's (CHE) VITAS Segment Inks New Deal With Covenant Care

Chemed’s CHE wholly owned subsidiary, VITAS Healthcare Corporation, recently entered into an agre...

Zacks via Yahoo Finance 14 Mar 2024

Centene (CNC), Pearl Health Unite to Enhance Value-Based Care

Centene Corporation’s CNC Medicare brand, Wellcare, recently announced its partnership with a sta...

Zacks via Yahoo Finance 13 Mar 2024

Teladoc Health (TDOC) Unveils Solution to Ease Weight Loss

Teladoc Health, Inc. TDOC recently enhanced its weight management capabilities in a bid to offer ...

Zacks via Yahoo Finance 11 Mar 2024

Chemed Corporation (NYSE:CHE) Q4 2023 Earnings Call Transcript

Chemed Corporation (NYSE:CHE) Q4 2023 Earnings Call Transcript February 28, 2024 Chemed Corporati...

Insider Monkey via Yahoo Finance 29 Feb 2024